Kadimastem Ltd
KDST
Rank in Stocks
#40945
Kadimastem Ltd is a biopharmaceutical company focused on pioneering... Kadimastem Ltd is a biopharmaceutical company focused on pioneering regenerative medical treatments. These therapies are developed using cells sourced from human embryonic stem cells, primarily targeting neurodegenerative diseases. Its development pipeline features AstroRx, a clinical-grade human astrocyte product currently undergoing Phase 1/2a clinical trials for amyotrophic lateral sclerosis (ALS) and various other neurodegenerative conditions. Additionally, the company is advancing IsletRx, a clinical-grade pancreatic islet cell therapy intended for the treatment of diabetes. Incorporated in 2008, Kadimastem is headquartered in Ness Ziona, Israel.
Share Price
$12.16
Last synced: 2025-10-30
Market Cap
$50.98K
Change (1 day)
-0.10%
Change (1 year)
69.56%
Country
IL
Trade Kadimastem Ltd (KDST)
Category
Healthcare
Market Capitalization of Kadimastem Ltd(KDST)
Market Cap: $50.98K
As of October 2026 Kadimastem Ltd has a market cap of $50.98K. This makes Kadimastem Ltd the world's 40945th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Kadimastem Ltd from 2021 to 2026
KDST compared with Top 5 Most Popular stocks
